MDS approval for HM oral agent
Posted: Wed Jul 08, 2020 3:20 pm
interesting - this is what BP alluded to where the FDA took into account the present pandemic in granting the approval to help those patients avoid the hospital and decrease their covid risk - HMA's are not approved in Europe
one thing we have not mentioned besides the limited blood supply is possibly Covid transmission with transfusion - these are patients that will have a high mortality rate with Covid - hopefully this can help tip the scales to approval in Europe
one thing we have not mentioned besides the limited blood supply is possibly Covid transmission with transfusion - these are patients that will have a high mortality rate with Covid - hopefully this can help tip the scales to approval in Europe